Targeted exome sequencing in anti-factor H antibody negative HUS reveals multiple variations

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Clinical and Experimental Nephrology

• Publication date

  2018-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10157-017-1478-6PMID 28939980
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.

  2017cited by this paper
• High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies.

  2016cited by this paper
• Comprehensive Analysis of Complement Genes in Patients with Atypical Hemolytic Uremic Syndrome

  2016cited by this paper
• Anti-complement-factor H-associated glomerulopathies

  2016cited by this paper
• Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome.

  2016cited by this paper
• A global reference for human genetic variation

  2015cited by this paper
• Atypical aHUS: State of the art.

  2015cited by this paper
• Atypical hemolytic uremic syndrome: Korean pediatric series

  2015cited by this paper
• The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome

  2015cited by this paper
• Analysis of protein-coding genetic variation in 60,706 humans

  2015cited by this paper
• KBG Syndrome: A Case Report and Longitudinal Assessment of Long‐Acting Recombinant Human Growth Hormone Therapy

  2015cited by this paper
• A general framework for estimating the relative pathogenicity of human genetic variants

  2014cited by this paper
• Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children.

  2014cited by this paper
• Guidelines for investigating causality of sequence variants in human disease

  2014cited by this paper
• Complement mutations in diacylglycerol kinase-ε-associated atypical hemolytic uremic syndrome.

  2014cited by this paper
• Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome.

  2014cited by this paper
• Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults.

  2013cited by this paper
• Atypical Hemolytic Uremic Syndrome

  2013cited by this paper
• Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.

  2013cited by this paper
• Analysis of genetic and predisposing factors in Japanese patients with atypical hemolytic uremic syndrome.

  2013cited by this paper
• Partial ADAMTS13 deficiency in atypical hemolytic uremic syndrome.

  2013cited by this paper
• What is complex about complex disorders?

  2012cited by this paper
• Anti-glomerular basement membrane glomerulonephritis and thrombotic microangiopathy in first degree relatives; a case report

  2012cited by this paper
• Common genetic variants in complement genes other than CFH, CD46 and the CFHRs are not associated with aHUS

  2012cited by this paper
• Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies.

  2012cited by this paper
• Disease-associated N-terminal Complement Factor H Mutations Perturb Cofactor and Decay-accelerating Activities*

  2011cited by this paper
• Atypical hemolytic uremic syndrome

  2011cited by this paper
• Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome.

  2010cited by this paper
• Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome

  2010cited by this paper
• Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype.

  2010cited by this paper
• A novel mutation in the Complement Factor B gene (CFB) and atypical hemolytic uremic syndrome

  2010cited by this paper
• Next-generation DNA sequencing

  2008cited by this paper
• Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation.

  2008cited by this paper
• Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome.

  2007cited by this paper
• The interactive Factor H–atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models

  2007cited by this paper
• Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32.

  2005cited by this paper
• Human Gene Mutation Database (HGMD®): 2003 update

  2003cited by this paper

• Thrombotic Microangiopathy in children: Redefining HUS, TTP and related disorders!

  2024cites this paper
• Anti-factor B antibodies in atypical hemolytic uremic syndrome

  2024influential citation
• Dysregulation of Immune Cell Subpopulations in Atypical Hemolytic Uremic Syndrome

  2023cites this paper
• Diarrhea could be a triggering factor in atypical hemolytic uremic syndrome in children

  2023cites this paper
• Thrombotic microangiopathy in children

  2022cites this paper
• Copy number variation analysis using next-generation sequencing identifies the CFHR3/CFHR1 deletion in atypical hemolytic uremic syndrome: a case report

  2022cites this paper
• Complement Factor H Gene Variant in a Patient with Thrombotic Microangiopathy on a Mixed Clinical Background

  2021cites this paper
• Atypical hemolytic uremic syndrome in Brazil: clinical presentation, genetic findings and outcomes of a case series in adults and children treated with eculizumab

  2020influential citation
• Complement in Secondary Thrombotic Microangiopathy

  2020cites this paper
• Genetic Testing in Pediatric Kidney Disease

  2020influential citation
• Hemolytic uremic syndrome in a developing country: Consensus guidelines

  2019cites this paper
• Clinical and Immunological Profile of Anti-factor H Antibody Associated Atypical Hemolytic Uremic Syndrome: A Nationwide Database

  2019cites this paper